Psychopharmacologic treatment of eating disorders: emerging findings (Q38386296)

2 September 2017

1 reference

title

Psychopharmacologic treatment of eating disorders: emerging findings (English)

1 reference

2 September 2017

1 reference

1

Susan L McElroy

1 reference

2 September 2017

4

Paul E Keck

1 reference

2 September 2017

2

Anna I Guerdjikova

1 reference

2 September 2017

Nicole Mori

3

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 May 2015

1 reference

Current Psychiatry Reports

2 September 2017

published in

1 reference

2 September 2017

volume

17

1 reference

2 September 2017

issue

5

1 reference

2 September 2017

page(s)

35

1 reference

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S11920-015-0573-1

Current pharmacotherapy options for bulimia nervosa and binge eating disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-015-0573-1

Biological therapies for eating disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-015-0573-1

Current and emerging drug treatments for binge eating disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-015-0573-1

Use of fluoxetine in anorexia nervosa before and after weight restoration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-015-0573-1

A Placebo-Controlled Pilot Study of Adjunctive Olanzapine for Adolescents with Anorexia Nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-015-0573-1

A double-blind, placebo-controlled study of risperidone for the treatment of adolescents and young adults with anorexia nervosa: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-015-0573-1

Double-blind placebo-controlled trial of quetiapine in anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-015-0573-1

Dronabinol in severe, enduring anorexia nervosa: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-015-0573-1

The impact of intranasal oxytocin on attention to social emotional stimuli in patients with anorexia nervosa: a double blind within-subject cross-over experiment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-015-0573-1

Intranasal oxytocin attenuates attentional bias for eating and fat shape stimuli in patients with anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-015-0573-1

The (lack of) effect of alprazolam on eating behavior in anorexia nervosa: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-015-0573-1

Dehydroepiandrosterone treatment effects on weight, bone density, bone metabolism and mood in women suffering from anorexia nervosa-a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-015-0573-1

Impact of physiologic estrogen replacement on anxiety symptoms, body shape perception, and eating attitudes in adolescent girls with anorexia nervosa: data from a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-015-0573-1

Olanzapine therapy in anorexia nervosa: psychobiological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-015-0573-1

Olanzapine in the treatment of low body weight and obsessive thinking in women with anorexia nervosa: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-015-0573-1

Are antipsychotics effective for the treatment of anorexia nervosa? Results from a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-015-0573-1

The effect of atypical antipsychotic medications in individuals with anorexia nervosa: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-015-0573-1

Meta analysis on the efficacy of pharmacotherapy versus placebo on anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-015-0573-1

Antipsychotic agents in the treatment of anorexia nervosa: neuropsychopharmacologic rationale and evidence from controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-015-0573-1

Challenges in conducting a multi‐site randomized clinical trial comparing treatments for adolescent anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-015-0573-1

Gastric emptying and symptoms of bulimia nervosa: Effect of a prokinetic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-015-0573-1

Duloxetine in the treatment of binge eating disorder with depressive disorders: a placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-015-0573-1

Bupropion for overweight women with binge-eating disorder: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-015-0573-1

Orlistat with behavioral weight loss for obesity with versus without binge eating disorder: randomized placebo-controlled trial at a community mental health center serving educationally and economically disadvantaged Latino/as.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-015-0573-1

Treatment of binge eating disorder in racially and ethnically diverse obese patients in primary care: randomized placebo-controlled clinical trial of self-help and medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-015-0573-1

A placebo-controlled pilot study of the novel opioid receptor antagonist ALKS-33 in binge eating disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-015-0573-1

Baclofen reduces binge eating in a double-blind, placebo-controlled, crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-015-0573-1

A double-blind, randomized pilot trial of chromium picolinate for binge eating disorder: results of the Binge Eating and Chromium (BEACh) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-015-0573-1

Cognitive behavioral therapy guided self-help and orlistat for the treatment of binge eating disorder: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-015-0573-1

Effect of orlistat in obese patients with binge eating disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-015-0573-1

A Randomized, Double-blind, Placebo-Controlled Study of Sibutramine in the Treatment of Binge-Eating Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-015-0573-1

Use of sibutramine, an inhibitor of the reuptake of serotonin and noradrenaline, in the treatment of binge eating disorder: a placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-015-0573-1

Efficacy of sibutramine for the treatment of binge eating disorder: a randomized multicenter placebo-controlled double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-015-0573-1

The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-015-0573-1

A randomized, placebo-controlled trial of sertraline in the treatment of night eating syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-015-0573-1

Escitalopram for treatment of night eating syndrome: a 12-week, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-015-0573-1

A pilot double-blind placebo-controlled trial of low-dose pramipexole in sleep-related eating disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-015-0573-1

Efficacy of rimonabant in obese patients with binge eating disorder

21 January 2018

1 reference

12 December 2020

Atomoxetine in the treatment of binge-eating disorder: a randomized placebo-controlled trial

1 reference

12 December 2020

Olanzapine versus placebo for out-patients with anorexia nervosa

1 reference

12 December 2020

Effect of dronabinol therapy on physical activity in anorexia nervosa: a randomised, controlled trial

1 reference

12 December 2020

The assessment of binge eating severity among obese persons.

1 reference

12 December 2020

Comparison of methods for identifying and assessing obese patients with binge eating disorder in primary care settings

1 reference

12 December 2020

10.1007/S11920-015-0573-1

Identifiers

DOI

1 reference

Dimensions Publication ID

2 September 2017

1002736997

0 references

1 reference